In The States – Page 369 – Weekly news about states

New York

NACDS and the Chain Pharmacy Association of New York State met with the New York State (NYS) Bureau of Immunizations to discuss pharmacy participation in the federally-funded Vaccines for Children program. Also, the state is developing a Memorandum of Understand (MOU) for chain pharmacies so that the state has a method of communicating with pharmacies in the case of a pandemic. Once that MOU is complete, NACDS will distribute it to members operating in the state.

Also in New York…NACDS and the Chain Pharmacy Association of New York State met with the NYS Bureau of Narcotic Enforcement (BNE) to discuss the opioid tax assessment program and the drug disposal program. The opioid tax assessment program enacted earlier this year will result in additional revenue to the state totaling $100 million annually. The invoices to the impacted drug manufacturers and wholesale distributors have been sent. In addition, the newly enacted statewide drug disposal legislation has a series of 2019 target dates. We have asked BNE to hold a stakeholder meeting to ensure that all interested parties continue to participate in the development of the program.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Karen White2018-12-10T09:12:27-05:00December 6, 2018|New York|

Ohio

NACDS submitted comments to the Board of Pharmacy on a proposed rule modifying the requirements for reporting to the state’s prescription drug monitoring program (PDMP). Specifically, NACDS asked the Board to clarify that pharmacies are required to submit a patient’s phone number as the patient identifier where it is available. Additionally, NACDS asked the Board to change a requirement that pharmacies notify the Board of PDMP submission errors to requiring such a notification only where the submission error cannot be corrected within seven days.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Karen White2018-12-10T09:13:00-05:00December 6, 2018|Ohio|

Michigan

The Michigan Pharmacists Association announced the results of its Executive Board elections. Meijer Pharmacy Compliance Director Mollien was voted president-elect. Charlie also serves on the state’s Board of Pharmacy.

For more information, contact NACDS’ Joel Kurzman at 847-905-0555.

Karen White2018-12-10T09:42:37-05:00November 15, 2018|Michigan|

New York

NACDS participated in the Board of Pharmacy meeting. A significant portion of the meeting focused on electronic prescribing and best practices. The next meeting of the Board is scheduled for Tuesday, March 12, 2019 in Albany.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Karen White2018-12-10T09:40:15-05:00November 15, 2018|New York|

Texas

NACDS submitted comments to the Health and Human Services Commission in support of a draft policy to limit opioid prescriptions to a maximum of seven days for opioid naïve clients across all of Medicaid, including traditional fee-for-service and managed care.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2018-12-10T09:38:10-05:00November 15, 2018|Texas|

Michigan

The Michigan Pharmacists Association announced the results of its Executive Board elections. Meijer Pharmacy Compliance Director Mollien was voted president-elect. Charlie also serves on the state’s Board of Pharmacy.

For more information, contact NACDS’ Joel Kurzman at 847-905-0555.

Karen White2018-11-16T08:36:04-05:00November 15, 2018|Michigan|

New York

NACDS participated in the Board of Pharmacy meeting. A significant portion of the meeting focused on electronic prescribing and best practices. The next meeting of the Board is scheduled for Tuesday, March 12, 2019 in Albany.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Karen White2018-11-16T08:33:41-05:00November 15, 2018|New York|

Texas

NACDS submitted comments to the Health and Human Services Commission in support of a draft policy to limit opioid prescriptions to a maximum of seven days for opioid naïve clients across all of Medicaid, including traditional fee-for-service and managed care.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2018-11-16T08:31:30-05:00November 15, 2018|Texas|

California

Effective October 28, the Department of Health Care Services (DHCS) lifted its moratorium on the enrollment of pharmacy providers for the Medi-Cal fee-for-service program in Los Angeles County. For more information, contact the Provider Enrollment Message Center at 916-323-1945 or submit your question via e-mail or NACDS’ Mary Staples at 817-442-1155.

Also in California…In mid-November, DHCS will publish an article in the Medi-Cal Pharmacy Updates bulletin informing providers seeking the higher of the two professional dispensing fees on drug claims for Fiscal Year 2019-20 that the next attestation will start in January 2019 for calendar year 2018 claim volume. If your company would like to centralize the coordination of attestations, please contact Trudi Balestreri.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2018-11-16T08:45:15-05:00November 8, 2018|California|